Market Research Logo

Lebanon Pharmaceuticals and Healthcare Report Q2 2015

Lebanon Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seekingtreatment in the country has sharply risen. Continued political instability will negatively impact governmentpolicy regarding healthcare and will in turn put the pharmaceutical sector at risk. However, high per capitaspending, an increasing burden of non-communicable diseases along with efforts by the Health Ministry totackle high levels of corruption within the sector will help sustain market growth in the coming years.

Headline Expenditure Projections

Pharmaceuticals: LBP2,394.38bn (USD1.59bn) in 2014 to LBP2,594.09bn (USD1.60bn) in 2015;+8.3% in local currency and +0.7% in US dollar terms.

Healthcare: LBP5,581.06bn (USD3.70bn) in 2014 to LBP6,071.98bn (USD3.74bn) in 2015; +8.8% inlocal currency and +1.1% US dollar terms.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaeutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lebanon 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Lebanon 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Lebanon 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Activity
Table: Lebanon - Operational Risk
Table: Economic Activity (Lebanon 2009-2018)
Industry Risk Reward Ratings
Middle East And Africa Risk/Reward Index
Lebanon Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Insurance
Medical Tourism
Regional Healthcare Collaboration
Clinical Trials
Regulatory Development
Regulatory Developments
Counterfeit Drugs
Public Sector Procurement
Intellectual Property Regime
Free Trade Agreements
Pricing Regime
Reimbursement Regime
Competitive Landscape
Pharmaceutical Sector
Pharmaceutical Sector Developments
Pharmaceutical Distribution
Retail Pharmacy Sector
Company Profile
Benta Pharmaceutical Industries (BPI)
Pharmaline
Chalhoub Pharmaceuticals (CHAPHA)
Alfa Laboratories
Algorithm
Codipha
Pfizer
Novartis
Merck & Co
Johnson & Johnson (J&J)
Sanofi
GlaxoSmithKline (GSK)
Abbott Laboratories
Demographic Forecast
Lebanon Demographic Forecast
Table: Population Headline Indicators (Lebanon 1990-2025)
Table: Key Population Ratios (Lebanon 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Lebanon 1990-2025)
Table: Population By Age Group (Lebanon 1990-2025)
Table: Population By Age Group % (Lebanon 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report